European measles cases doubled in 2024 after vaccination levels fell post-COVID-19
Children under 5 accounted for more than 40% of the 127,350 cases reported last year in the region, the World Health ...
The Manila Times19h
STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States
STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as ...